Protein-protein interaction network analysis of cirrhosis liver disease

Gastroenterology and Hepatology from Bed to Bench

Volumn 9, Issue 2, 2016, Pages 114-123

  Safaei, Akram ^a   Tavirani, Mostafa Rezaei ^b   Oskouei, Afsaneh Arefi ^a   Azodi, Mona Zamanian ^b   Mohebbi, Seyed Reza ^a   Nikzamir, Abdol Rahim ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; DAVID bioinformatics resources 6.7; Gene ontology; Protein protein interaction network

Indexed keywords

ALPHA POLYPEPTIDE I; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; CALPONIN; CALPONIN 1; COMPLEMENT COMPONENT C7; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GALECTIN 3; GALECTIN 4; LECTIN; MICROFIBRILLAR ASSOCIATED PROTEIN 4; POLYPEPTIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN DERIVATIVE; TRANSGELIN; TROPOMYOSIN; TROPOMYOSIN 2; TROPOMYOSIN 4; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL ORGANELLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; GENE ONTOLOGY; HOMEOSTASIS; LIPID METABOLISM; LIVER CIRRHOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 84964394240     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838-51.
2. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19(3):271-85.
3. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003; 27:209-19.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88:125-72.
5. Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L, King BP, et al. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer 2009; 9:1471-2407.
6. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36:962-72.
7. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006; 74:756-62.
8. Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, Cai AJ, et al. 1H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis. World J Gastroenterol 2012; 18:285-90.
9. Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench 2011; 4:175.
10. Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med 2009; 47:305-10.
11. Mas VR, Maluf DG, Archer KJ, Yanek K, Bornstein K, Fisher RA. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation 2009; 87:143-52.
12. Molleken C, Sitek B, Henkel C, Poschmann G, Sipos B, Wiese S, et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009; 49:1257-66.
13. Rodrigo L, Alvarez V, Rodriguez M, Perez R, Alvarez R, Coto E. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study. Scand J Gastroenterol 1999; 34:303-07.
14. Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, et al. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004; 39:518-27.
15. Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012; 5:1755-536.
16. Zamanian-Azodi M, Rezaei-Tavirani M, Hasanzadeh H, Rad SR, Dalilan S. Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach. Gastroenterol Hepatol Bed Bench 2015; 8:6.
17. Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi AA. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol Hepatol Bed Bench 2014; 7:17-31.
18. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4(1):44-57.
19. Ghamari E, Zali H, Rezaie Tavirani M, Hesami Takalu S, Goshadrou F, Ahmadi N, et al. Proteomic study in the rat hippocampus as a measure of human Alzheimer's disease. Koomesh 2015; 16:611-20. [In Persian]
20. Liu H, Hu ZZ, Wu CH. DynGO: a tool for visualizing and mining of gene ontology and its associations. BMC Bioinformatics 2005; 6:201.
21. Lee JS, Katari G, Sachidanandam R. GObar: a gene ontology based analysis and visualization tool for gene sets. BMC Bioinformatics 2005; 6:189.
22. Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 2007; 8(9): R183.
23. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008; 4:44-57.
24. Da Wei Huang BTS, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID gene ID conversion tool. Bioinformation 2008; 2:428.
25. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37:1-13.
26. Zali H, Zamanian-Azodi M, Tavirani MR, Baghban AA-z. Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer's disease. Iran J Pharm Res. 2015; 14:291.
27. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9.1: proteinprotein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41:29.
28. Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Rezaei Tavirani M, Seyyedi SS. Protein-protein interaction network could reveal the relationship between the breast and colon cancer. Gastroenterol Hepatol Bed Bench 2015; 8:215-24.
29. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 2003; 31:258-61.
30. Wunsch E, Milkiewicz M, Wasik U, Trottier J, Kempińska-Podhorodecka A, Elias E, et al. Expression of hepatic fibroblast growth factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease. Sci Rep 2015; 5:13462.
31. Cheung KJ, Libbrecht L, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol 2010; 22:1066-73.
32. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6:674-87.
33. Tipney H, Hunter L. An introduction to effective use of enrichment analysis software. Hum Genomics 2010; 4:202-6.
34. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jarvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42:320-30.
35. Larter CZ, Chitturi S, Heydet D, Farrell GC. A fresh look at NASH pathogenesi. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010; 25:672-90.
36. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med 2009; 87:679-95.
37. Rombouts K, Marra F. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis 2010; 28:229-35.
38. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55:560-78.
39. Gonzalez-Angulo AM, Ferrer-Lozano J, Stemke-Hale K, Sahin A, Liu S, Barrera JA, et al. PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer. Mol Cancer Ther 2011;10:1093-101.
40. Dharancy S, Louvet A, Hollebecque A, Desreumaux P, Mathurin P, Dubuquoy L. Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects. Gastroenterol Clin Biol 2008; 32:339-50.
41. Peyrou M, Ramadori P, Bourgoin L, Foti M. PPARs in liver diseases and cancer: epigenetic gegulation by MicroRNAs. PPAR Res 2012; 757803:13.
42. Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, et al. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. PLoS One 2015; 10: e0122961.
43. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med 2007; 11:1031-51.
44. Nakagawa H, Maeda S. Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Patholog Res Int 2012; 172894:14.
45. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997; 273: G602-11.
46. Waanders E, Van Krieken JH, Lameris AL, Drenth JP. Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease. Mod Pathol 2008; 21:1293-302.
47. Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol 2015; 7:1974-81.
48. McIntyre N. Plasma lipids and lipoproteins in liver disease. Gut 1978; 19:526-30.
49. Rezaei-Tavirani M, Zamanian-Azodi M, Rajabi S, Masoudi-Nejad A, Rostami-Nejad M, Rahmatirad S. Protein clustering and interactome analysis in Parkinson and Alzheimer's diseases. Arch Iran Med 2016; 19:101-9.
50. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nat Rev Drug Discov 2008; 7:84-99.
51. Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C. Serum prostacyclin stabilizing factor is identical to apolipoprotein AI (Apo AI). A novel function of Apo AI. J Clin Invest 1988; 82:803.
52. Binns D, Dimmer E, Huntley R, Barrell D, O'Donovan C, Apweiler R. QuickGO: a web-based tool for Gene Ontology searching. Bioinformatics 2009; 25:3045-46.